World's Best Scientists 2026 revealed!
Akinori Takaoka

Akinori Takaoka

D-Index & Metrics

Biology and Biochemistry

D-Index
48
Citations
25376
World Ranking
18173
National Ranking
1307

Overview

Akinori Takaoka is a researcher affiliated with Hokkaido University in Japan. Their work spans multiple fields including Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. The scientist's research output includes a strong focus on Immunology, Molecular Biology, Epidemiology, Infectious Diseases, and Oncology.

The primary research topics covered by Akinori Takaoka include:

  • Interferon and immune responses
  • Immune Response and Inflammation
  • COVID-19 Clinical Research Studies
  • MicroRNA in disease regulation
  • HIV Research and Treatment
  • Hepatitis C virus research
  • Bacterial Identification and Susceptibility Testing

The scientist has published in several well-known venues, with frequent appearances in:

  • Scientific Reports
  • Nature Immunology
  • Cancers
  • iScience
  • Inflammation and Regeneration

Among the recent key publications authored or co-authored by Akinori Takaoka are:

  • "RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells," 2021, Nature Immunology
  • "MicroRNA-30e-5p has an Integrated Role in the Regulation of the Innate Immune Response during Virus Infection and Systemic Lupus Erythematosus," 2020, iScience
  • "Loss of PARP7 Increases Type I Interferon Signaling in EO771 Breast Cancer Cells and Prevents Mammary Tumor Growth by Increasing Antitumor Immunity," 2023, Cancers
  • "Innate immune recognition against SARS-CoV-2," 2023, Inflammation and Regeneration
  • "Cleavage of TANK-Binding Kinase 1 by HIV-1 Protease Triggers Viral Innate Immune Evasion," 2021, Frontiers in Microbiology

Collaborations have involved multiple frequent coauthors, including:

  • Seiichi Sato
  • Taisho Yamada
  • Ashish Kumar
  • Akhilesh Kumar
  • Himanshu Kumar

Best Publications

  • IRF-7 is the master regulator of type-I interferon-dependent immune responses

    Kenya Honda;Hideyuki Yanai;Hideo Negishi;Masataka Asagiri

  • DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response

    Akinori Takaoka;Zhichao Wang;Myoung Kwon Choi;Hideyuki Yanai

  • Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors

    Kenya Honda;Akinori Takaoka;Tadatsugu Taniguchi

  • T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.

    Hiroshi Takayanagi;Kouetsu Ogasawara;Shigeaki Hida;Tomoki Chiba

  • Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

    Akinori Takaoka;Hideyuki Yanai;Seiji Kondo;Gordon Duncan

  • Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction.

    Kenya Honda;Yusuke Ohba;Yusuke Ohba;Hideyuki Yanai;Hideo Negishi

  • Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

    Akinori Takaoka;Sumio Hayakawa;Hideyuki Yanai;Dagmar Stoiber;Dagmar Stoiber

  • Comparing antibody and small-molecule therapies for cancer

    Kohzoh Imai;Akinori Takaoka

  • Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

    Shigeki Chiba;Muhammad Baghdadi;Hisaya Akiba;Hironori Yoshiyama

  • Interferon signalling network in innate defence.

    Akinori Takaoka;Hideyuki Yanai

  • The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors.

    Tadatsugu Taniguchi;Akinori Takaoka

  • Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling

    Kenya Honda;Hideyuki Yanai;Tatsuaki Mizutani;Hideo Negishi

  • A weak signal for strong responses: interferon-alpha/beta revisited.

    Tadatsugu Taniguchi;Akinori Takaoka

  • Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells

    Masahisa Jinushi;Shigeki Chiba;Hironori Yoshiyama;Kenkichi Masutomi

  • Negative regulation of Toll-like-receptor signaling by IRF-4

    Hideo Negishi;Yusuke Ohba;Hideyuki Yanai;Akinori Takaoka

  • Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection

    Kenya Honda;Shinya Sakaguchi;Chigusa Nakajima;Ai Watanabe

  • The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus

    Seiichi Sato;Kai Li;Takeshi Kameyama;Takaya Hayashi

  • Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules.

    ZhiChao Wang;Myoung Kwon Choi;Tatsuma Ban;Hideyuki Yanai

  • Cross Talk Between Interferon-γ and -α/β Signaling Components in Caveolar Membrane Domains

    Akinori Takaoka;Yukiko Mitani;Hirofumi Suemori;Mitsuharu Sato

  • Integral role of Noxa in p53-mediated apoptotic response

    Tsukasa Shibue;Kiyoshi Takeda;Eri Oda;Hiroshi Tanaka

Frequent Co-Authors

Tadatsugu Taniguchi
Tadatsugu Taniguchi University of Tokyo
Kenya Honda
Kenya Honda Keio University
Yusuke Ohba
Yusuke Ohba Hokkaido University
Kohzoh Imai
Kohzoh Imai University of Tokyo
Yuji Hinoda
Yuji Hinoda Yamaguchi University
Minoru Toyota
Minoru Toyota Sapporo Medical University
Shizuo Akira
Shizuo Akira Osaka University
Hiroshi Takayanagi
Hiroshi Takayanagi University of Tokyo
Tomohiko Tamura
Tomohiko Tamura Yokohama City University
Yasuhito Tanaka
Yasuhito Tanaka Kumamoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Akinori Takaoka

Trending Scientists